These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica. Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400 [TBL] [Abstract][Full Text] [Related]
29. Soluble Fas and soluble FasL in multiple organ dysfunction syndrome complicating diffuse peritonitis. Kitamura M; Endo S; Sato N; Yaegashi Y; Suxzuki Y; Kojika N; Wakabayashi G Res Commun Mol Pathol Pharmacol; 2004; 115-116():235-42. PubMed ID: 17564320 [TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Sarchielli P; Di Filippo M; Ercolani MV; Chiasserini D; Mattioni A; Bonucci M; Tenaglia S; Eusebi P; Calabresi P Neurosci Lett; 2008 Apr; 435(3):223-8. PubMed ID: 18353554 [TBL] [Abstract][Full Text] [Related]
31. The dynamics of soluble Fas/APO 1 apoptotic biochemical marker in acute ischemic stroke patients. Mahovic D; Zurak N; Lakusic N; Sporis D; Zarkovic N; Stancin N; Bosnar-Puretic M Adv Med Sci; 2013; 58(2):298-303. PubMed ID: 24277959 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury. Uzan M; Erman H; Tanriverdi T; Sanus GZ; Kafadar A; Uzun H Acta Neurochir (Wien); 2006 Nov; 148(11):1157-64; discussion. PubMed ID: 16964558 [TBL] [Abstract][Full Text] [Related]
33. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis. Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033 [TBL] [Abstract][Full Text] [Related]
34. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis]. Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Lee KS; Choi YH; Kim YS; Baik SH; Oh YJ; Sheen SS; Park JH; Hwang SC; Park KJ Respir Med; 2008 Mar; 102(3):464-9. PubMed ID: 17988850 [TBL] [Abstract][Full Text] [Related]
36. The interleukin-10 levels as a potential indicator of positive response to interferon beta treatment of multiple sclerosis patients. Bartosik-Psujek H; Stelmasiak Z Clin Neurol Neurosurg; 2006 Oct; 108(7):644-7. PubMed ID: 16343740 [TBL] [Abstract][Full Text] [Related]
37. Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis. Boylan MT; Crockard AD; McDonnell GV; McMillan SA; Hawkins SA Immunol Lett; 2001 Oct; 78(3):183-7. PubMed ID: 11578693 [TBL] [Abstract][Full Text] [Related]
38. Serum prolactin level in patients with multiple sclerosis: a case control study. Harirchian MH; Sahraian MA; Shirani A Med Sci Monit; 2006 Apr; 12(4):CR177-80. PubMed ID: 16572053 [TBL] [Abstract][Full Text] [Related]